GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » EV-to-EBITDA

Mangalam Drugs & Organics (BOM:532637) EV-to-EBITDA : 10.99 (As of Oct. 31, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Mangalam Drugs & Organics's enterprise value is ₹2,825 Mil. Mangalam Drugs & Organics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was ₹257 Mil. Therefore, Mangalam Drugs & Organics's EV-to-EBITDA for today is 10.99.

The historical rank and industry rank for Mangalam Drugs & Organics's EV-to-EBITDA or its related term are showing as below:

BOM:532637' s EV-to-EBITDA Range Over the Past 10 Years
Min: -192.12   Med: 6.28   Max: 34.43
Current: 10.99

During the past 13 years, the highest EV-to-EBITDA of Mangalam Drugs & Organics was 34.43. The lowest was -192.12. And the median was 6.28.

BOM:532637's EV-to-EBITDA is ranked better than
63.57% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.78 vs BOM:532637: 10.99

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-10-31), Mangalam Drugs & Organics's stock price is ₹111.65. Mangalam Drugs & Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₹-4.036. Therefore, Mangalam Drugs & Organics's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Mangalam Drugs & Organics EV-to-EBITDA Historical Data

The historical data trend for Mangalam Drugs & Organics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics EV-to-EBITDA Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.69 4.12 5.51 21.91 18.05

Mangalam Drugs & Organics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.44 -187.55 27.02 18.05 6.40

Competitive Comparison of Mangalam Drugs & Organics's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangalam Drugs & Organics's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's EV-to-EBITDA falls into.



Mangalam Drugs & Organics EV-to-EBITDA Calculation

Mangalam Drugs & Organics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2825.265/257.055
=10.99

Mangalam Drugs & Organics's current Enterprise Value is ₹2,825 Mil.
Mangalam Drugs & Organics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹257 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics  (BOM:532637) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Mangalam Drugs & Organics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=111.65/-4.036
=At Loss

Mangalam Drugs & Organics's share price for today is ₹111.65.
Mangalam Drugs & Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.036.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Mangalam Drugs & Organics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics Business Description

Traded in Other Exchanges
Address
P. D\'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. The company is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise sales in the Indian and overseas markets. The single operating segment of the company is the Manufacturing of Bulk Drugs.

Mangalam Drugs & Organics Headlines

No Headlines